ConductScience.org, home

Paper785256

The carrier potential of liposomes in biology and medicine (second of two parts).

Gregoriadis G. N Engl J Med, 1976. Cited by 295 papers, by iCite.

Cite this record

ConductScience Library. The carrier potential of liposomes in biology and medicine (second of two parts). Papers, record 785256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/785256

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The carrier potential of liposomes in biology and medicine (second of two parts).
PubMed
Journal
N Engl J Med
PubMed
Year
1976
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
295
iCite
Relative citation ratio, by iCite
8.24
iCite
Revised in PubMed
2018-11-30
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gregoriadis GG

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LiposomesMajor topic
Adjuvants, Immunologic
Animals
Blood Proteins
Cell Membrane
Cells
Cells, Cultured
Diabetes Mellitus
Enzyme Therapy
Enzymes
Humans
Lysosomes
Metabolism, Inborn Errors
Neoplasms
Pharmaceutical Preparations

Source PubMed

Download CSV of topics

Cited by56

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 295 citations.

PMIDTitleJournalYearIn PapersSource
42934758Nanoparticles and their significant risks: a comprehensive review of toxicological and regulatory perspectives.J Nanobiotechnology2026https://conductscience.org/library/papers/42934758PubMed
42781592Multifunctional Hybrid Nanomedicines for Neurodegenerative Diseases: A Paradigm Shift from Rational Design to Clinical Translation.Int J Nanomedicine2026https://conductscience.org/library/papers/42781592PubMed
42428904A Novel Capillary Electrophoresis Capacitively Coupled Contactless Conductivity Detection (CE‑C4D) Method for Quantification of Ionic Excipients in Doxorubicin HCl Liposome Injection.ACS Omega2026https://conductscience.org/library/papers/42428904PubMed
41766818mRNA vaccines transform personalized lung cancer treatment.Front Immunol2025https://conductscience.org/library/papers/41766818PubMed
40872482Novel Strategies for the Formulation of Poorly Water-Soluble Drug Substances by Different Physical Modification Strategies with a Focus on Peroral Applications.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40872482PubMed
39885941Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective.BMJ Oncol2025https://conductscience.org/library/papers/39885941PubMed
39179112Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies.J Control Release2024https://conductscience.org/library/papers/39179112PubMed
38888787RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens.Methods Mol Biol2024https://conductscience.org/library/papers/38888787PubMed
38072115An Automated Electroanalytical Method for the Drug Release Profiling of Liposomal Doxorubicin HCl Formulations.J Pharm Sci2024https://conductscience.org/library/papers/38072115PubMed
37164241Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caused COVID-19 and other viral diseases.J Control Release2023https://conductscience.org/library/papers/37164241PubMed
36232973Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy.Int J Mol Sci2022https://conductscience.org/library/papers/36232973PubMed
36003616Liposomes as Multifunctional Nano-Carriers for Medicinal Natural Products.Front Chem2022https://conductscience.org/library/papers/36003616PubMed
35335906Liposomes as Tools to Improve Therapeutic Enzyme Performance.Pharmaceutics2022https://conductscience.org/library/papers/35335906PubMed
35214191The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA.Pharmaceutics2022https://conductscience.org/library/papers/35214191PubMed
34575441Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics.Pharmaceutics2021https://conductscience.org/library/papers/34575441PubMed
33932543Nanotechnology-based approaches for emerging and re-emerging viruses: Special emphasis on COVID-19.Microb Pathog2021https://conductscience.org/library/papers/33932543PubMed
32638101Enhancing the antimalarial activity of artesunate.Parasitol Res2020https://conductscience.org/library/papers/32638101PubMed
31717337Advances in Lipid and Metal Nanoparticles for Antimicrobial Peptide Delivery.Pharmaceutics2019https://conductscience.org/library/papers/31717337PubMed
31286060Evolution of macromolecular complexity in drug delivery systems.Nat Rev Chem2017https://conductscience.org/library/papers/31286060PubMed
30991632Extracellular Vesicles as Biological Shuttles for Targeted Therapies.Int J Mol Sci2019https://conductscience.org/library/papers/30991632PubMed

See all 56 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/785256

GET https://conductscience.org/api/papers/v1/785256/cited_by?page=2